Clinical trial
Long Study - Longitudinal Thrombosis in End Stage Renal Disease
NCT00157664 · Hamilton Health Sciences Corporation, Other · Unknown status
Key facts
| NCT number | NCT00157664 |
|---|---|
| Title | Long Study - Longitudinal Thrombosis in End Stage Renal Disease |
| Official title | Canadian Longitudinal Thrombosis in End Stage Renal Disease Pilot Study |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Canadian Institutes of Health Research (CIHR) |
| Status | Unknown status |
| Study type | Observational |
| Conditions | End Stage Renal Disease, Thrombosis, Bleeding, Cardiovascular Disease |
| Enrollment | 400 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 17, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: